Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 12280149
Manufacturing of bupivacaine multivesicular liposomes
granted -
US 12281078
Quinoline cGAS antagonist compounds
granted -
US 12280122
Muscle targeting complexes and uses thereof for treating myotonic dystrophy
granted -
US 12280037
Method and pharmaceutical composition for treating or preventing trichomoniasis and uses thereof
granted -
US 12280063
Anti-retroviral therapies and reverse transcriptase inhibitors for treatment of Alzheimer's disease
granted -
US 12280124
Antibody-drug conjugates comprising GLP1 peptidomimetics and uses thereof
granted -
US 12280113
Ras inhibitors
granted -
US 12280140
Processes for production of tumor infiltrating lymphocytes and uses of the same in immunotherapy
granted -
US 12281327
Lymphohematopoietic engineering using CAS9 base editors
granted -
US 12280120
Tumor-specific cleavable linkers
granted -
US 12280055
Combination therapies
granted -
US 12280089
Dry powder formulation of caveolin-1 peptides and methods of use thereof
granted -
CN 119857078
PARP inhibitor child preparation and preparation process thereof
granted -
US 12280046
Melanocortin subtype-2 receptor (MC2R) antagonist for the treatment of disease
granted -
US 12280032
Methods and compositions for increasing the potency of antifungal agents
granted -
US 12281336
Chikungunya virus (CHIKV) virus-like particles (VLPS) comprising the C, E1, and E2 structural proteins
granted -
US 12281136
Crystalline forms of a CD73 inhibitor and uses thereof
granted -
US 12281329
Compositions and methods for immune cell modulation in adoptive immunotherapies
granted -
US 12281173
Methods for treating patients with hyperlipidemia by administering a PCSK9 inhibitor in combination with an ANGPTL3 inhibitor
granted -
US 12281164
Genetically engineered dual-targeting chimeric antigen receptor and use thereof
granted -
US 12281310
Use of trinucleotide repeat RNAs to treat cancer
granted -
US 12280029
Methods of treatment of inflammation related conditions using pluripotent anti-inflammatory and metabolic modulators
granted -
US 12281321
Frataxin expression constructs having engineered promoters and methods of use thereof
granted -
US 12281073
Substituted piperidine compound and use thereof
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.